BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 26970490)

  • 21. Pathogenesis of ANCA-associated vasculitides.
    Kallenberg CG
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i59-63. PubMed ID: 21339221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of ANCA-associated vasculitis, an update.
    Kallenberg CG
    Clin Rev Allergy Immunol; 2011 Oct; 41(2):224-31. PubMed ID: 21336557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High mobility group box 1 contributes to anti-neutrophil cytoplasmic antibody-induced neutrophils activation through receptor for advanced glycation end products (RAGE) and Toll-like receptor 4.
    Wang C; Wang H; Chang DY; Hao J; Zhao MH; Chen M
    Arthritis Res Ther; 2015 Mar; 17(1):64. PubMed ID: 25889374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The involvement of NETs in ANCA-associated vasculitis.
    Shiratori-Aso S; Nakazawa D
    Front Immunol; 2023; 14():1261151. PubMed ID: 37781373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement in ANCA-associated vasculitis.
    Charles Jennette J; Xiao H; Hu P
    Semin Nephrol; 2013 Nov; 33(6):557-64. PubMed ID: 24161040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of ANCA-associated vasculitis.
    Flint J; Morgan MD; Savage CO
    Rheum Dis Clin North Am; 2010 Aug; 36(3):463-77. PubMed ID: 20688244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage migration inhibitory factor contributes to anti-neutrophil cytoplasmic antibody-induced neutrophils activation.
    Hao J; Lv TG; Wang C; Xu LP; Zhao JR
    Hum Immunol; 2016 Dec; 77(12):1209-1214. PubMed ID: 27544048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New pathophysiological insights and treatment of ANCA-associated vasculitis.
    Wilde B; van Paassen P; Witzke O; Tervaert JWC
    Kidney Int; 2011 Mar; 79(6):599-612. PubMed ID: 21150876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein enhances activation of coagulation system and inflammatory response through dissociating into monomeric form in antineutrophil cytoplasmic antibody-associated vasculitis.
    Xu PC; Lin S; Yang XW; Gu DM; Yan TK; Wei L; Wang BL
    BMC Immunol; 2015 Mar; 16():10. PubMed ID: 25879749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity.
    Sangaletti S; Tripodo C; Chiodoni C; Guarnotta C; Cappetti B; Casalini P; Piconese S; Parenza M; Guiducci C; Vitali C; Colombo MP
    Blood; 2012 Oct; 120(15):3007-18. PubMed ID: 22932797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease.
    Jennette JC; Falk RJ
    Nat Rev Rheumatol; 2014 Aug; 10(8):463-73. PubMed ID: 25003769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of ANCA-associated vasculitis: recent insights from animal models.
    van Timmeren MM; Heeringa P
    Curr Opin Rheumatol; 2012 Jan; 24(1):8-14. PubMed ID: 22089093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement in antineutrophil cytoplasmic antibody-associated vasculitis.
    Yuan J; Chen M; Zhao MH
    Clin Exp Nephrol; 2013 Oct; 17(5):642-645. PubMed ID: 23180036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Schreiber A; Kettritz R
    J Leukoc Biol; 2013 Oct; 94(4):623-31. PubMed ID: 23381471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental models of vasculitis and glomerulonephritis induced by antineutrophil cytoplasmic autoantibodies.
    Jennette JC; Xiao H; Falk R; Gasim AMH
    Contrib Nephrol; 2011; 169():211-220. PubMed ID: 21252521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. At the Bench: Neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases.
    Grayson PC; Kaplan MJ
    J Leukoc Biol; 2016 Feb; 99(2):253-64. PubMed ID: 26432901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune regulatory mechanisms in ANCA-associated vasculitides.
    Lepse N; Abdulahad WH; Kallenberg CG; Heeringa P
    Autoimmun Rev; 2011 Dec; 11(2):77-83. PubMed ID: 21856453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutrophils from vasculitis patients exhibit an increased propensity for activation by anti-neutrophil cytoplasmic antibodies.
    Ohlsson SM; Ohlsson S; Söderberg D; Gunnarsson L; Pettersson Å; Segelmark M; Hellmark T
    Clin Exp Immunol; 2014 Jun; 176(3):363-72. PubMed ID: 24666336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN.
    Zhao L; David MZ; Hyjek E; Chang A; Meehan SM
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):54-62. PubMed ID: 25516918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.
    Savage CO
    Clin Exp Immunol; 2011 May; 164 Suppl 1(Suppl 1):23-6. PubMed ID: 21447127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.